← Leaderboards
Lovick Edward Cannon
Novab, Inc.
$986,005
Attributed
$1,216,917
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $302K · FY2014–23$500K$375K$250K$125K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,216,917 · 6
By mechanism
R43$1,080,751 · 5
R41$136,166 · 1
Top collaborators
- Max D Cooper2 shared
- Christopher Bradley Doering1 shared
- Brantley Herrin1 shared
- H Trent Spencer1 shared
Others in their field
Top investigators on “Antigen Receptors”
- Barton F Haynes · Duke University$185,054,185
- Leonidas A Stamatatos · Fred Hutchinson Cancer Center$41,827,359
- Ellis L Reinherz · Dana-Farber Cancer Institute$41,046,156
- David Wofsy · University Of California, San Francisco$34,011,973
- Luc Teyton · Scripps Research Institute, The$32,181,486
- James L Riley · University Of Pennsylvania$31,011,151
Research focus
Antigen ReceptorsAntigen BindingLeucine-Rich RepeatAntigensAntibodiesBinding SitesSpecificityLampreysHagfishReceptorLymphocyteVertebratesCellsSurfaceFc ReceptorEngineeringPolypeptideImmunoglobulinsReagentStructureImmunizationImmune SystemCarbohydratesImmune
Grant awards (6)
Novel targeted CAR-T multiple myeloma therapy$301,956
R43 · FY2023 · CA · contact PI
Novel antibody polymer reagents for SARS-CoV-2 detection$256,506
R43 · FY2021 · AI · contact PI
Monoclonal antibodies specific for biologically relevant glycans$223,366
R43 · FY2019 · GM · contact PI
Monoclonal lamprey VLR antibodies specific for mucin-type O-linked glycan core 1 - 4 structures$136,166
R41 · FY2017 · GM · contact PI
Humanization of VLR antibodies for therapeutic applications$149,887
R43 · FY2015 · CA · contact PI
VLR-CART Cancer Immunotherapy$149,036
R43 · FY2014 · CA · contact PI